Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
ECTRIMS 2015 video update Bouma: Parallel Session 2 New challenges in clinical trial design
jun 2017